News
-
MARCH 23, 2026
Advancing global health: UC Davis test identifies active, infectious form of TB
UC Davis researchers developed a blood test that quickly identifies active TB for faster diagnosis and treatment.
Read More -
MARCH 19, 2026How an imbalanced gut microbiome worsens chronic kidney disease
Researchers have identified how chronic kidney disease turbocharges E. coli toxin production, worsening the disease. An investigational drug might break the destructive feedback loop.
Read More -
MARCH 16, 2026New training model helps surgeons practice minimally invasive spina bifida repair
Engineers at UC Davis Tech Foundry and medical professionals at UC Davis Health have developed a teaching model to train surgeons on fetoscopic repair of spina bifida.
Read More -
FEBRUARY 26, 2026First-ever in-utero stem cell therapy for fetal spina bifida repair is safe, study finds
A UC Davis Health research team has safely performed the world’s first spina bifida treatment combining fetal surgery with stem cells, according to results from Phase 1 of an ongoing clinical trial. These results have been published today in The Lancet.
Read More -
FEBRUARY 25, 2026UC Davis medical school among nation’s best in NIH funding
The UC Davis School of Medicine is among the nation’s top-NIH funded medical schools, with about $233 in grants, in latest Blue Ridge Institute ranking
Read More
